Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

ClinicalTrials.gov ID: NCT00510198

Public ClinicalTrials.gov record NCT00510198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PRECEDE-HF -Prospective, Randomized Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

Study identification

NCT ID: NCT00510198
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Congestive Heart Failure

Interventions

Cardiac Compass with OptiVol Fluid Status Monitoring Device
Standard of Care alone (clinical assessment) Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2007
Primary completion: Mar 31, 2009
Completion: Mar 31, 2009
Last update posted: Apr 9, 2019

2007 – 2009

United States locations

U.S. sites: 33
U.S. states: 23
U.S. cities: 33

Facility	City	State	ZIP	Site status
Not listed	Anchorage	Alaska	99508	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Berkeley	California	94705	—
Not listed	Larkspur	California	94939	—
Not listed	Colorado Springs	Colorado	80909	—
Not listed	Fort Collins	Colorado	80528	—
Not listed	Jacksonville	Florida	32207	—
Not listed	Atlanta	Georgia	30306	—
Not listed	Kankakee	Illinois	60901	—
Not listed	Oak Lawn	Illinois	60453	—
Not listed	Rockford	Illinois	61107	—
Not listed	Indianapolis	Indiana	46260	—
Not listed	Louisville	Kentucky	40205	—
Not listed	New Orleans	Louisiana	70121	—
Not listed	Takoma Park	Maryland	20912	—
Not listed	Springfield	Massachusetts	01199	—
Not listed	Saginaw	Michigan	48601	—
Not listed	Ypsilanti	Michigan	48197	—
Not listed	Saint Cloud	Minnesota	56303	—
Not listed	Saint Joseph	Missouri	64501	—
Not listed	St Louis	Missouri	63110	—
Not listed	Albany	New York	12212	—
Not listed	Akron	Ohio	44304	—
Not listed	Cleveland	Ohio	44195	—
Not listed	Columbus	Ohio	43210	—
Not listed	Elyria	Ohio	44035	—
Not listed	Oklahoma City	Oklahoma	73120	—
Not listed	Doylestown	Pennsylvania	18901	—
Not listed	Lancaster	Pennsylvania	17603	—
Not listed	Nashville	Tennessee	37205	—
Not listed	Austin	Texas	78705	—
Not listed	Richmond	Virginia	23294	—
Not listed	Milwaukee	Wisconsin	53215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00510198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 9, 2019 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00510198 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →